Palace denies mismanagement in vaccine procurement

Malacañang denied claims of mismanagement in the procurement process as a reason for the delay in COVID-19 vaccine delivery to the Philippines, attributing it instead to issues with indemnity and regulatory approval.

Presidential Spokesperson Harry Roque insisted that the absence of an indemnification law and regulatory approval were the sole reasons for the delay, not mismanagement.

Roque cited a letter from the WHO's COVAX Facility indicating vaccines were expected in mid-February.

He mentioned that vaccine manufacturers were concerned due to the Philippines' past experience with Dengvaxia, where charges were filed despite approvals, contributing to the delay.

Despite the delay, Roque announced that the government will soon begin the immunization program after the FDA gave the green light for the emergency use of Sinovac vaccines.

He taunted critics who he said were "rejoicing" over the delay, stating their happiness would be short-lived.

Senate Majority Leader Franklin Drilon, however, maintained that the delay was due to mismanagement of the procurement process.